CLAIMEL
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that CLAIMEL, filed by Glaxo Group Limited, is no longer active – it was abandoned on March 7 2011 because no Statement of Use was filed after the Notice of Allowance was issued. The only goods listed are “pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of … and for vaccines” in International Class 005, so a similar name used for medicines or vaccines would be the closest area of concern. The record does not give Glaxo control over every possible use of the word CLAIMEL in other industries. Because the application was on the Principal Register and never moved to the Supplemental Register, there is no supplemental‑register sequence to note. The latest meaningful event is the abandonment notice mailed on March 7 2011, and the history shows no oppositions, cancellations or court actions. I'd treat this as a moderate concern if you plan a pharmaceutical‑related brand with a similar name.
Informational only - not legal advice.Mark Trademark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Jun 14, 2007 |
| Published for opposition | Nov 13, 2007 |
| Notice of Allowance | Feb 05, 2008 |
| Status date | Mar 07, 2011 |
Goods & services
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines
Owner & representation
| Owner | Glaxo Group Limited |
| Address | Berkeley Avenue, Glaxo Wellcome House, Greenford, Middlesex UNITED KINGDOM UB60NN |
| Entity | CORPORATION - organized in UNITED KINGDOM |
| Attorney of record | Maribeth Day Case |
| Correspondent | Maribeth Day Case |
| Attorney email | t********@*****.com |
| Correspondent email | t********@*****.com |
| Correspondent phone | 9********3 |
| Correspondent address | RESEARCH TRIANGLE PARK, NORTH |